HSBC Holdings’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-30,480
| Closed | -$379K | – | 2859 |
|
|
2016
Q4 | $379K | Buy |
30,480
+2,867
| +10% | +$34.5K | ﹤0.01% | 2046 |
|
|
2016
Q3 | $378K | Buy |
27,613
+27,000
| +4,405% | +$271K | ﹤0.01% | 1659 |
|
|
2016
Q2 | $5K | Sell |
613
-27,000
| -98% | -$203K | ﹤0.01% | 2034 |
|
|
2016
Q1 | $177K | Buy |
27,613
+575
| +2% | +$3.22K | ﹤0.01% | 1955 |
|
|
2015
Q4 | $169K | Sell |
27,038
-4,619
| -15% | -$30.3K | ﹤0.01% | 2101 |
|
|
2015
Q3 | $185K | Sell |
31,657
-3,928
| -11% | -$30.3K | ﹤0.01% | 1817 |
|
|
2015
Q2 | $294K | Sell |
35,585
-66
| -0.2% | -$584 | ﹤0.01% | 1624 |
|
|
2015
Q1 | $293K | Sell |
35,651
-1,193
| -3% | -$8.82K | ﹤0.01% | 1758 |
|
|
2014
Q4 | $253K | Buy |
36,844
+8,151
| +28% | +$51K | ﹤0.01% | 1645 |
|
|
2014
Q3 | $155K | Buy |
28,693
+1,693
| +6% | +$9.89K | ﹤0.01% | 1688 |
|
|
2014
Q2 | $172K | Sell |
27,000
-5,696
| -17% | -$39.2K | ﹤0.01% | 1704 |
|
|
2014
Q1 | $264K | Buy |
+32,696
| New | +$255K | ﹤0.01% | 1560 |
|
|
2013
Q4 | – | Sell |
-14,334
| Closed | -$264K | – | 1753 |
|
|
2013
Q3 | $264K | Buy |
14,334
+3,443
| +32% | +$66.8K | ﹤0.01% | 1534 |
|
|
2013
Q2 | $191K | Buy |
+10,891
| New | +$193K | ﹤0.01% | 1450 |
|
Other funds holding ARIA
HSBC Holdings's ARIA Position: Q1 2017 in Review
HSBC Holdings sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 30,480 shares — an estimated $379K sold.
HSBC Holdings first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $379K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- HSBC Holdings reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- HSBC Holdings sold 30,480 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $379K.
- HSBC Holdings first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- HSBC Holdings's Ariad Pharmaceuticals Inc position peaked at $379K in Q4 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.